James B. Tananbaum
Director at Latigo Biotherapeutics · 15 reported transactions in 2 companies · latest trade Aug 10, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +321.7%, S&P 500 +10.9% over the same days.
Their trades
Bought | Aug 10, 2026 | Aug 10, 2026 close $18.56 → Oct 29, 2026 close $15.54. S&P 500 −0.1% over the same days. | ||
Bought | Jan 8, 2026 | Jan 8, 2026 close $18.18 → Oct 27, 2026 close $6.64. S&P 500 +11.6% over the same days. | ||
Bought | Jan 8, 2026 | Jan 8, 2026 close $18.18 → Oct 27, 2026 close $6.64. S&P 500 +11.6% over the same days. |
BoughtLatigo Biotherapeutics
$2.52M
Aug 10, 2026 close $18.56 → Oct 29, 2026 close $15.54. S&P 500 −0.1% over the same days.
BoughtAlumis
$5M
Jan 8, 2026 close $18.18 → Oct 27, 2026 close $6.64. S&P 500 +11.6% over the same days.
BoughtAlumis
$2M
Jan 8, 2026 close $18.18 → Oct 27, 2026 close $6.64. S&P 500 +11.6% over the same days.